1.The Effects of Toki-Shyakuyaku-San on Alzheimer's Disease.
Kampo Medicine 1997;47(5):861-867
Tokishakuyaku-san has traditionally been used for the treatment of symptoms associated with gynecological diseases. It has recently been suggested, however, that this Kampo formula may also be useful in the treatment of senile demetia. The author experienced five cases of Alzheimer's disease which responded to Tokishakuyaku-san. They were diagnosed by clinical features, neuropsychiatric examinations, CT, MRI and SPECT. Tokishakuyaku-san was administered for at least twelve months. Some cases showed improvement in the dementia scale. Wandering, hyperactivity, and loss of will were reduced in some patients. Tokishakuyaku-san seems to decrease the progression of the disease course.
Various studies have suggested that senile dementia is associated with disruption of the cholinergic system of the brain. Studies involving rats have shown that Tokishakuyaku-san reduces the cognitive disruption caused by central cholinergic dysfunction, and increases the number of nicotinic receptors and the concentration of noradrenaline in the cerebral cortex. Thus, Tokishakuyaku-san may reduce central cholinergic dysfuntion by facilitating brain cholinergic and/or noradrenergic function. It may therefore prove to be a useful therapy for senile dementia.
2.Current Status in the Treatment of Acute Cholecystitis Patients Receiving Antithrombotic Therapy: Is Endoscopic Drainage Feasible?- A Systematic Review
Ryota SAGAMI ; Kenji HAYASAKA ; Hidefumi NISHIKIORI ; Hideaki HARADA ; Yuji AMANO
Clinical Endoscopy 2020;53(2):176-188
The bleeding complication risk of surgery or percutaneous transhepatic gallbladder drainage (PTGBD) may increase in patients with acute cholecystitis receiving antithrombotic therapy (ATT). Endoscopic gallbladder drainage (EGBD) may be recommended for such patients. English articles published between 1991 and 2018 in peer-reviewed journals that discuss cholecystectomy, PTGBD, and EGBD in patients with ATT or coagulopathy were reviewed to assess the safety of the procedures, especially in terms of the bleeding complication. There were 8 studies on cholecystectomy, 3 on PTGBD, and 1 on endoscopic transpapillary gallbladder drainage (ETGBD) in patients receiving ATT. With respect to EGBD, 28 studies on ETGBD (including 1 study already mentioned above) and 26 studies on endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) were also analyzed. The overall bleeding complication rate in patients with ATT who underwent cholecystectomy was significantly higher than that in patients without ATT (6.5% [23/354] vs. 1.2% [26/2,224], p<0.001). However, the bleeding risk of cholecystectomy and PTGBD in patients receiving ATT was controversial. The overall technical success, clinical success, and bleeding complication rates of ETGBD vs. EUS-GBD were 84% vs. 96% (p<0.001), 92% vs. 97% (p<0.001), and 0.65% vs. 2.1% (p=0.005), respectively. One patient treated with ETGBD experienced bleeding complication among 191 patients with bleeding tendency. ETGBD may be an ideal drainage procedure for patients receiving ATT from the viewpoint of bleeding, although EUS-GBD is also efficacious.
3.A New Technique of Endoscopic Transpapillary Gallbladder Drainage Combined with Intraductal Ultrasonography for the Treatment of Acute Cholecystitis
Ryota SAGAMI ; Kenji HAYASAKA ; Tetsuro UJIHARA ; Ryotaro NAKAHARA ; Daisuke MURAKAMI ; Tomoyuki IWAKI ; Satoshi SUEHIRO ; Yasushi KATSUYAMA ; Hideaki HARADA ; Yuji AMANO
Clinical Endoscopy 2020;53(2):221-229
Background/Aims:
Endoscopic transpapillary gallbladder drainage (ETGBD) is useful for the treatment of acute cholecystitis; however, the technique is difficult to perform. When intraductal ultrasonography (IDUS) is combined with ETGBD, the orifice of the cystic duct in the common bile duct may be more easily detected in the cannulation procedure. The aim of this study was to evaluate the efficacy of ETGBD with IDUS compared with that of ETGBD alone.
Methods:
A total of 100 consecutive patients with acute cholecystitis requiring ETGBD were retrospectively recruited. The first 50 consecutive patients were treated using ETGBD without IDUS, and the next 50 patients were treated using ETGBD with IDUS. Through propensity score matching analysis, we compared the clinical outcomes between the groups. The primary outcome was the technical success rate.
Results:
The technical success rate of ETGBD with IDUS was significantly higher than that of ETGBD without IDUS (92.0% vs. 76.0%, p=0.044). There was no significant difference in procedure length between the two groups (74.0 min vs. 66.7 min, p=0.310). The complication rate of ETGBD with IDUS was significantly higher than that of ETGBD without IDUS (6.0% vs. 0%, p<0.001); however, only one case showed an IDUS technique-related complication (pancreatitis).
Conclusions
The assistance of IDUS may be useful in ETGBD.